These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37347163)

  • 1. Tandem Guest-Host-Receptor Recognitions Precisely Guide Ciprofloxacin to Eliminate Intracellular Staphylococcus aureus.
    Zhan W; Xu L; Liu Z; Liu X; Gao G; Xia T; Cheng X; Sun X; Wu FG; Yu Q; Liang G
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306427. PubMed ID: 37347163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Study of the Adaptive Mechanism of Ciprofloxacin-Resistant
    Liu J; Wei Q; Wang Z; Sun X; He QY
    J Proteome Res; 2022 Jun; 21(6):1537-1547. PubMed ID: 35594371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria "E. coli; P. aeruginosa; Saureus; and MRSA" and their infections.
    Nwabuife JC; Omolo CA; Govender T
    J Control Release; 2022 Sep; 349():338-353. PubMed ID: 35820538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic Self-Assembly of Adamantane-Peptide Conjugate for Combating Staphylococcus aureus Infection.
    Zhan W; Gao G; Liu Z; Liu X; Xu L; Wang M; Xu HD; Tang R; Cao J; Sun X; Liang G
    Adv Healthc Mater; 2023 Jul; 12(18):e2203283. PubMed ID: 36880480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.
    Dey S; Majhi A; Mahanti S; Dey I; Bishayi B
    Inflammation; 2015; 38(3):1050-69. PubMed ID: 25429758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of Dispersin B with Cyclodextrin-Ciprofloxacin Derivatives for Treating Staphylococcal.
    Abdelkader J; Alelyani M; Alashban Y; Alghamdi SA; Bakkour Y
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
    Krut O; Sommer H; Krönke M
    J Antimicrob Chemother; 2004 Feb; 53(2):167-73. PubMed ID: 14729736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kill the Real with the Fake: Eliminate Intracellular Staphylococcus aureus Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug Carrier.
    Gao F; Xu L; Yang B; Fan F; Yang L
    ACS Infect Dis; 2019 Feb; 5(2):218-227. PubMed ID: 30489062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between resistance phenotype and gene expression in response to serial exposure to oxacillin and ciprofloxacin in Staphylococcus aureus.
    Uddin MJ; Ahn J
    Lett Appl Microbiol; 2017 Dec; 65(6):462-468. PubMed ID: 28977678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS Turn Nanoparticle Fluorescence on for Imaging Staphylococcus aureus Infection In Vivo.
    Xu L; Zhan W; Deng Y; Liu X; Gao G; Sun X; Liang G
    Adv Healthc Mater; 2022 Jul; 11(14):e2200453. PubMed ID: 35521978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection.
    Gao G; Jiang YW; Jia HR; Wu FG
    Biomaterials; 2019 Jan; 188():83-95. PubMed ID: 30339942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
    Sun M; Zhu C; Long J; Lu C; Pan X; Wu C
    Drug Deliv; 2020 Dec; 27(1):632-641. PubMed ID: 32329376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
    Rolin O; Huet Y; Bouanchaud DH
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():49-52. PubMed ID: 2940215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based discrimination of differentially expressed proteins in antibiotic-sensitive and antibiotic-resistant Salmonella Typhimurium, Klebsiella pneumoniae, and Staphylococcus aureus.
    Uddin MJ; Ma CJ; Kim JC; Ahn J
    Arch Microbiol; 2019 Nov; 201(9):1259-1275. PubMed ID: 31240342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating methicillin-resistant
    Ashar H; Singh A; Ektate K; More S; Ranjan A
    Int J Hyperthermia; 2023; 40(1):2211278. PubMed ID: 37437891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
    Seral C; Carryn S; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes.
    Silva SWC; Monção NBN; Araújo BQ; Arcanjo DDR; Ferreira JHL; Lima Neto JS; Citó AMGL; de Siqueira Júnior JP; Kaatz GW; Barreto HM
    Lett Appl Microbiol; 2019 Jul; 69(1):57-63. PubMed ID: 31002429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plantaricin A reverses resistance to ciprofloxacin of multidrug-resistant Staphylococcus aureus by inhibiting efflux pumps.
    Meng F; Nie T; Lyu Y; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Environ Microbiol; 2022 Oct; 24(10):4818-4833. PubMed ID: 36254863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-targeted metallo-ciprofloxacin derivatives rationally designed and developed to overcome antimicrobial resistance.
    Ude Z; Flothkötter N; Sheehan G; Brennan M; Kavanagh K; Marmion CJ
    Int J Antimicrob Agents; 2021 Dec; 58(6):106449. PubMed ID: 34644603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.